Literature DB >> 25377218

Applying micro-costing methods to estimate the costs of pharmacy interventions: an illustration using multi-professional clinical medication reviews in care homes for older people.

Tracey H Sach1, James Desborough2, Julie Houghton3, Richard Holland1.   

Abstract

OBJECTIVES: Economic methods are underutilised within pharmacy research resulting in a lack of quality evidence to support funding decisions for pharmacy interventions. The aim of this study is to illustrate the methods of micro-costing within the pharmacy context in order to raise awareness and use of this approach in pharmacy research.
METHODS: Micro-costing methods are particularly useful where a new service or intervention is being evaluated and for which no previous estimates of the costs of providing the service exist. This paper describes the rationale for undertaking a micro-costing study before detailing and illustrating the process involved. The illustration relates to a recently completed trial of multi-professional medication reviews as an intervention provided in care homes. All costs are presented in UK£2012. KEY
FINDINGS: In general, costing methods involve three broad steps (identification, measurement and valuation); when using micro-costing, closer attention to detail is required within all three stages of this process. The mean (standard deviation; 95% confidence interval (CI) ) cost per resident of the multi-professional medication review intervention was £104.80 (50.91; 98.72 to 109.45), such that the overall cost of providing the intervention to all intervention home residents was £36,221.29 (95% CI, 32 810.81 to 39 631.77).
CONCLUSIONS: This study has demonstrated that micro-costing can be a useful method, not only for estimating the cost of a pharmacy intervention to feed into a pharmacy economic evaluation, but also as a source of information to help inform those designing pharmacy services about the potential time and costs involved in delivering such services.
© 2014 Royal Pharmaceutical Society.

Entities:  

Keywords:  bottom-up costing; care homes; micro-costing; older people; pharmacy

Year:  2014        PMID: 25377218     DOI: 10.1111/ijpp.12162

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  5 in total

Review 1.  Interventions for preventing falls in older people in care facilities and hospitals.

Authors:  Ian D Cameron; Suzanne M Dyer; Claire E Panagoda; Geoffrey R Murray; Keith D Hill; Robert G Cumming; Ngaire Kerse
Journal:  Cochrane Database Syst Rev       Date:  2018-09-07

2.  Development of a pharmaceutical care program in progressive stages in geriatric institutions.

Authors:  Conxita Mestres; Marta Hernandez; Anna Agustí; Laura Puerta; Blanca Llagostera; Patricia Amorós
Journal:  BMC Geriatr       Date:  2018-12-19       Impact factor: 3.921

3.  Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis.

Authors:  Clémence Perraudin; Aline Bourdin; Alex Vicino; Thierry Kuntzer; Olivier Bugnon; Jérôme Berger
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

4.  Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmácia®).

Authors:  Suzete Costa; José Guerreiro; Inês Teixeira; Dennis K Helling; João Pereira; Céu Mateus
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

5.  Seizure First Aid Training For people with Epilepsy (SAFE) frequently attending emergency departments and their significant others: results of a UK multi-centre randomised controlled pilot trial.

Authors:  Adam J Noble; Dee Snape; Sarah Nevitt; Emily A Holmes; Myfanwy Morgan; Catrin Tudur-Smith; Dyfrig A Hughes; Mark Buchanan; Jane McVicar; Elizabeth MacCallum; Steve Goodacre; Leone Ridsdale; Anthony G Marson
Journal:  BMJ Open       Date:  2020-04-16       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.